Literature DB >> 24744135

Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.

Kazuhiro Kitajima1, Yasuhiko Ebina, Kazuro Sugimura.   

Abstract

Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) is a useful technique for acquiring both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session, and has opened up a new field of clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, treatment optimization, re-staging, therapy monitoring, and prognostication of uterine and ovarian cancers as well as various malignant tumors. The present review discusses the current role of FDG-PET/CT in the management of gynecologic malignancies, focusing on its usefulness and limitations for imaging such patients.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24744135     DOI： 10.1007/s11604-014-0317-x

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN： 1867-1071            Impact factor:   2.374


  51 in total

1.  Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer.

Authors:  Norbert Avril; Stefanie Sassen; Barbara Schmalfeldt; Joerg Naehrig; Stephan Rutke; Wolfgang A Weber; Martin Werner; Henner Graeff; Markus Schwaiger; Walther Kuhn
Journal:  J Clin Oncol       Date:  2005-09-12       Impact factor: 44.544

2.  Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements.

Authors:  Tira Bunyaviroch; Timothy G Turkington; Terence Z Wong; John W Wilson; James G Colsher; R Edward Coleman
Journal:  Mol Imaging Biol       Date:  2007-12-21       Impact factor: 3.488

3.  Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers.

Authors:  Sadahiko Nishizawa; Masayuki Inubushi; Hiroyuki Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-14       Impact factor: 9.236

4.  Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors.

Authors:  Koichi Koyama; Terue Okamura; Joji Kawabe; Nozomi Ozawa; Kenzi Torii; Naohiko Umesaki; Masato Miyama; Hironobu Ochi; Ryusaku Yamada
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

5.  Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET.

Authors:  Lilie L Lin; Sasa Mutic; Daniel A Low; Richard LaForest; Milos Vicic; Imran Zoberi; Tom R Miller; Perry W Grigsby
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-01       Impact factor: 7.038

6.  FDG-PET/CT for diagnosis of primary ovarian cancer.

Authors:  Kazuhiro Kitajima; Kayo Suzuki; Michio Senda; Masato Kita; Yuji Nakamoto; Yumiko Onishi; Tetsuo Maeda; Takeshi Yoshikawa; Yoshiharu Ohno; Kazuro Sugimura
Journal:  Nucl Med Commun       Date:  2011-07       Impact factor: 1.690

7.  Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.

Authors:  Elizabeth A Kidd; Barry A Siegel; Farrokh Dehdashti; Janet S Rader; David G Mutch; Matthew A Powell; Perry W Grigsby
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

8.  Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.

Authors:  Tatsuo Torizuka; Toshihiko Kanno; Masami Futatsubashi; Hiroyuki Okada; Etsuji Yoshikawa; Fumitoshi Nakamura; Munetaka Takekuma; Makoto Maeda; Yasuomi Ouchi
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

9.  Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Ichio Fukasawa; Noriyuki Inaba; Narufumi Suganuma; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

10.  Does the novel integrated PET/MRI offer the same diagnostic performance as PET/CT for oncological indications?

Authors:  Jiahe Tian; Liping Fu; Dayi Yin; Jinming Zhang; Yingmao Chen; Ningyu An; Baixuan Xu
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240
View more
  1 in total

1.  Epithelioid leiomyoma of the uterus: A case report with magnetic resonance imaging findings.

Authors:  Ayaka Kita; Tetsuo Maeda; Kazuhiro Kitajima; Homare Murakoshi; Takahiro Watanabe; Mieko Inagaki; Shigeki Yoshida
Journal:  Case Rep Womens Health       Date:  2022-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.